<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00570934</url>
  </required_header>
  <id_info>
    <org_study_id>5387</org_study_id>
    <nct_id>NCT00570934</nct_id>
  </id_info>
  <brief_title>Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA</brief_title>
  <official_title>Effect of Supplementation With 2000 International Units (IU) Vitamin D, 1gm Calcium or Both on Calcium Absorption and Bone Mineralization in Children With Juvenile Rheumatoid Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Missouri-Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Missouri-Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      2000 international units (IU) vitamin D, 1 gram (gm) calcium, or both given to children with
      Juvenile Rheumatoid Arthritis (JRA) may increase percent true calcium absorption, bone
      mineral turnover and/or bone mineralization.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Supplementation With 2000 IU Vitamin D, 1 gm Calcium or Both on Calcium Absorption and Bone
      Mineralization in Children With Juvenile Rheumatoid Arthritis may increase percent true
      calcium absorption, bone mineral turnover and/or bone mineralization.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 1995</start_date>
  <completion_date type="Actual">February 2002</completion_date>
  <primary_completion_date type="Actual">February 2002</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent true calcium absorption</measure>
    <time_frame>After 6 months of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone Mineralization by Dual Energy x-ray absorption</measure>
    <time_frame>After 6 months treatment plus 3 month washout</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Juvenile Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>order of interventions placebo,calcium, cholecalciferol, calcium plus cholecalciferol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>order of treatment calcium, placebo, calcium plus cholecalciferol, cholecalciferol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>order of treatments cholecalciferol, calcium and Cholecalciferol, placebo, and calcium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium and cholecalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>order of treatment calcium and cholecalciferol, cholecalciferol, calcium, placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>2000IU Cholecalciferol P.O. Q.D.</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Calcium</arm_group_label>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_label>Calcium and cholecalciferol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium</intervention_name>
    <description>1 gm calcium as calcium carbonate</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Calcium</arm_group_label>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_label>Calcium and cholecalciferol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium and cholecalciferol</intervention_name>
    <description>2000IU cholecalciferol and 1 gm calcium P.O. Q.D. for 6 months</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Calcium</arm_group_label>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_label>Calcium and cholecalciferol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Calcium</arm_group_label>
    <arm_group_label>Cholecalciferol</arm_group_label>
    <arm_group_label>Calcium and cholecalciferol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Juvenile Rheumatoid arthritis

        Exclusion Criteria:

          -  Steroid use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura S Hillman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Missouri-Columbia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Missouri Hospitals and clinics</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2007</study_first_submitted>
  <study_first_submitted_qc>December 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2007</study_first_posted>
  <last_update_submitted>October 7, 2016</last_update_submitted>
  <last_update_submitted_qc>October 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

